Creating human brain models to study aggressive brain tumors in children
Human Organoid Models for Pediatric High-Grade Gliomas
This study is working on creating mini brain models from children's cells to learn more about aggressive brain tumors called pediatric high-grade gliomas, so we can find better treatments that actually help kids.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10727450 on NIH RePORTER |
What this research studies
This research focuses on developing human organoid models to better understand pediatric high-grade gliomas (pHGGs), which are aggressive brain tumors in children. By using patient-derived stem cells and human brain organoids, the team aims to replicate the tumor environment and study how these tumors interact with brain cells. The goal is to identify why existing treatments, like targeted therapies, are not effective in children and to explore new therapeutic strategies that could improve outcomes. This approach leverages advanced cell culture techniques to mimic the human brain's developmental and metabolic characteristics.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with pediatric high-grade gliomas, particularly those with specific genetic mutations in their tumors.
Not a fit: Patients with low-grade gliomas or other types of brain tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for pediatric high-grade gliomas, potentially improving survival rates and quality of life for affected children.
How similar studies have performed: While there has been significant research on gliomas, the use of human organoid models for pediatric high-grade gliomas is a relatively novel approach that has not been extensively tested.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Read, Renee D — Emory University
- Study coordinator: Read, Renee D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.